by Contributing Author | May 5, 2021 | Headline News
This article was originally published by Tyler Durden at ZeroHedge. Yesterday, Pfizer released a strong earnings report (surpassing Wall Street’s elevated projections), and also revealed that it’s both on the cusp of securing regulatory approval in the US...
